CJC-1295 manufacturers
- CJC-1295 with DA
-
- $105.00
-
2026-08-07
- CAS:446262-90-4
- Min. Order: 1BOX
- Purity: 99.9
- Supply Ability: 9999
- CJC-1295 & DAC
-
- $10.00
-
2026-08-07
- CAS:446262-90-4
- Min. Order: 1box
- Purity: 99.99%
- Supply Ability: 9999
- CJC With dac
-
-
2026-08-04
- CAS:446262-90-4
- Min. Order: 1box
- Purity: 99
- Supply Ability: 20
|
| | CJC-1295 Basic information |
| Product Name: | CJC-1295 | | Synonyms: | L-Lysinamide, L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-;CJC-1295 with DAC 5mg;CJC-1295 with DA;CJC With dac | | CAS: | 446262-90-4 | | MF: | | | MW: | 3367.9 | | EINECS: | | | Product Categories: | | | Mol File: | 446262-90-4.mol |  |
| | CJC-1295 Chemical Properties |
| | CJC-1295 Usage And Synthesis |
| Description |
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue (GHS) which was developed by ConjuChem Biotechnologies.
| | Uses |
CJC-1295 may markedly increase plasma growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels in animals and humans.
| | General Description | CJC-1295 is a 30 amino acid peptide analogue of the growth hormone releasing hormone (GHRH). Compared to the native protein sequence, CJC-1295 has four amino acid substitutions which improve protease resistance, and an additional lysine residue at the C terminus that incorporates a maleimidopropionic acid group. This maleimidopropionic acid, sometimes called the drug affinity complex (DAC), forms stable covalent linkages with free thiol groups on the surface of plasma proteins such as serum albumin . The conjugation of CJC-1295 to plasma proteins dramatically increases the biological stability of the drug, extending plasma half-life up to 6 – 8 days in humans[1]. | | References | [1] Mark Timms, Rohan S., Katherine Ganio. (2019). A method for confirming CJC-1295 abuse in equine plasma samples by LC–MS/MS. Drug Testing and Analysis, 11 8, 1248–1257. https://doi.org/10.1002/dta.2599 |
| | CJC-1295 Preparation Products And Raw materials |
|